Laura Pat Svetkey, MD

Professor of Medicine
Director of Clinical Research
Vice-chair for Faculty Development & Diversity in the Department of Medicine
Campus mail Duke Box 3703, Durham, NC 27710
Phone (919) 681-6386
Email address svetk001@mc.duke.edu

Laura P. Svetkey, MD MHS is Professor of Medicine/Nephrology, Vice Chair for Faculty Development and Diversity in the Department of Medicine, and School of Medicine Faculty Ombudsperson. She is also the Director of Duke’s CTSA-sponsored internal career development award program (KL2) and the Investigator Development Core of Duke’s REACH Equity Disparities Research Center.

Dr. Svetkey has over 30 years of experience in the investigation of hypertension, obesity, and related areas, conducting NIH-sponsored clinical research ranging from behavioral intervention trials to metabolomics and genetics, with a consistent focus on prevention, non-pharmacologic intervention, health disparities and minority health. Her research has affected national guidelines, having served on the 2013 national Hypertension Guideline Panel (JNC) and the Lifestyle Guideline Working Group. She is an American Society of Hypertension certified hypertension specialist, and a member of the Association of American Physicians (AAP). She is the Associate Director, Core Director and Project PI of Duke’s REACH Equity Disparities Research Center.

As Department of Medicine Vice Chair for Faculty Development and Diversity, she implements a wide range of programs to enhance the experience and advancement of faculty and trainees, with particular emphasis on under-represented minorities and women.

As School of Medicine Faculty Ombudsperson, she helps faculty resolve concerns by providing confidential, impartial, informal guidance.

Education and Training

  • Fellow in General Internal Medicine, Medicine, Duke University, 1982 - 1983
  • Resident in Medicine, Medicine, Montefiore Medical Center, 1980 - 1982
  • Intern in Medicine, Medicine, Montefiore Medical Center, 1979 - 1980
  • M.D., Harvard University , 1979

Publications

Erlinger, T. P., P. R. Conlin, R. F. Macko, A. D. Bohannon, E. R. Miller, T. J. Moore, L. P. Svetkey, and L. J. Appel. “The impact of angiotensin II receptor blockade and the DASH diet on markers of endogenous fibrinolysis..” J Hum Hypertens 16, no. 6 (June 2002): 391–97. https://doi.org/10.1038/sj.jhh.1001401.

PMID
12037693
Full Text

Carter-Edwards, L., S. A. Jackson, M. J. Runaldue, and L. P. Svetkey. “Diet- and blood pressure-related knowledge, attitudes, and hypertension prevalence among African Americans: The KDBP study.” Ethnicity and Disease 12, no. 1 (May 18, 2002).

Scholars@Duke

Szczech, L. A., L. J. Edwards, L. L. Sanders, C. van der Horst, J. A. Bartlett, A. E. Heald, and L. P. Svetkey. “Protease inhibitors are associated with a slowed progression of HIV-related renal diseases..” Clin Nephrol 57, no. 5 (May 2002): 336–41. https://doi.org/10.5414/cnp57336.

PMID
12036191
Full Text

Carter-Edwards, Lori, John T. Fisher, Benjamin J. Vaughn, and Laura P. Svetkey. “Church rosters: is this a viable mechanism for effectively recruiting African Americans for a community-based survey?.” Ethn Health 7, no. 1 (February 2002): 41–55. https://doi.org/10.1080/13557850220146984.

PMID
12119065
Full Text

Carter-Edwards, L., J. T. Fisher, B. J. Vaughn, and L. P. Svetkey. “Church rosters: Is this a viable mechanism for effectively recruiting African Americans for a community-based survey?.” Ethnicity & Health 7, no. 1 (February 1, 2002): 41–55. https://doi.org/10.1080/13557850220146984.

Full Text

Szczech, Lynda Anne, Stephen J. Gange, Charles van der Horst, John A. Bartlett, Mary Young, Mardge H. Cohen, Kathryn Anastos, Preston S. Klassen, and Laura P. Svetkey. “Predictors of proteinuria and renal failure among women with HIV infection..” Kidney Int 61, no. 1 (January 2002): 195–202. https://doi.org/10.1046/j.1523-1755.2002.00094.x.

PMID
11786101
Full Text

Carter-Edwards, Lori, Seronda A. Jackson, Maria J. Runaldue, and Laura P. Svetkey. “Diet- and blood pressure-related knowledge, attitudes, and hypertension prevalence among African Americans: the KDBP Study. Knowledge of Diet and Blood Pressure..” Ethnicity & Disease 12, no. 1 (January 2002).

PMID
11913625
Scholars@Duke

Vollmer, W. M., F. M. Sacks, J. Ard, L. J. Appel, G. A. Bray, D. G. Simons-Morton, P. R. Conlin, et al. “Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial..” Ann Intern Med 135, no. 12 (December 18, 2001): 1019–28. https://doi.org/10.7326/0003-4819-135-12-200112180-00005.

PMID
11747380
Full Text

Svetkey, L. P., T. J. Moore, D. G. Simons-Morton, L. J. Appel, G. A. Bray, F. M. Sacks, J. D. Ard, et al. “Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study..” J Hypertens 19, no. 11 (November 2001): 1949–56. https://doi.org/10.1097/00004872-200111000-00004.

PMID
11677359
Full Text

Obarzanek, E., M. A. Proschan, T. J. Moore, F. M. Sacks, L. P. Svetkey, L. J. Appel, W. M. Vollmer, M. M. Most-Windhauser, and J. A. Cutler. “Variability in blood pressure response to salt intake.” Circulation 104, no. 17 (October 23, 2001): 811–12.

Scholars@Duke

Pages